Risk of scleroderma according to the type of immune checkpoint inhibitors.
Terrier B, Humbert S, Preta LH, Delage L, Razanamahery J, Laurent-Roussel S, Mestiri R, Beaudeau L, Legendre P, Goupil F, Hadjadj J, Stolzenberg MC, Treluyer JM, Westeel V, Valnet-Rabier MB, Wislez M, Mouthon L, Chouchana L.
Terrier B, et al. Among authors: chouchana l.
Autoimmun Rev. 2020 Aug;19(8):102596. doi: 10.1016/j.autrev.2020.102596. Epub 2020 Jun 12.
Autoimmun Rev. 2020.
PMID: 32540450